Conceptions Inc News Today

Operator: Good afternoon, and welcome to the Co-Diagnostics, Inc. Fourth Quarter and Full Year 2022 Earnings Results Conference Call. All participants will be in a listen-only mode.

Co-Diagnostics, Inc. (NASDAQ:NASDAQ:CODX) Q1 2022 Earnings Conference Call May 12, 2022, 16:30 ET Company Participants Andrew Benson - Head, IR Dwight Egan - Chairman, CEO & President...

Co-Diagnostics, Inc. (NASDAQ:NASDAQ:CODX) Q4 2021 Results Conference Call March 24, 2022 04:30 PM ET Company Participants Andrew Benson - Head, IR Dwight Egan - CEO Brian Brown - CFO...

/PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular...

Co-Diagnostics (NASDAQ:CODX) Inc saw a healthy jump in year-over-year revenue driven by global sales of its Logix Smart COVID-19 tests, according to its...

The deal was made in order to streamline the commercialization of the Eikon platform and YourTest PCR device.

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of...

/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of...

SALT LAKE CITY, Dec. 31, 2021 /PRNewswire/ -- Co-Diagnostics, Inc.  , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,... | December 31, 2021

A glance at some of the days highlights from the Proactive Investors US and Canada newswires